These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

117 related items for PubMed ID: 1388278

  • 1. The 5-HT1A antagonist (-)-alprenolol fails to modify sleep or zimeldine-induced sleep-waking effects in rats.
    Bjorvatn B, Neckelmann D, Ursin R.
    Pharmacol Biochem Behav; 1992 May; 42(1):49-56. PubMed ID: 1388278
    [Abstract] [Full Text] [Related]

  • 2. Effects of zimeldine, a selective 5-HT reuptake inhibitor, combined with ritanserin, a selective 5-HT2 antagonist, on waking and sleep stages in rats.
    Bjorvatn B, Ursin R.
    Behav Brain Res; 1990 Nov 30; 40(3):239-46. PubMed ID: 2149499
    [Abstract] [Full Text] [Related]

  • 3. Sleep/waking and EEG power spectrum effects of a nonselective serotonin (5-HT) antagonist and a selective 5-HT reuptake inhibitor given alone and in combination.
    Bjorvatn B, Bjørkum AA, Neckelmann D, Ursin R.
    Sleep; 1995 Jul 30; 18(6):451-62. PubMed ID: 7481417
    [Abstract] [Full Text] [Related]

  • 4. Sleep/waking effects following intrathecal administration of the 5-HT(1A) Agonist 8-OH-DPAT alone and in combination with the putative 5-HT(1A) antagonist NAN-190 in rats.
    Bjørkum AA, Ursin R.
    Brain Res Bull; 1996 Jul 30; 39(6):373-9. PubMed ID: 9138747
    [Abstract] [Full Text] [Related]

  • 5. Increased waking as well as increased synchronization following administration of selective 5-HT uptake inhibitors to rats.
    Ursin R, Bjorvatn B, Sommerfelt L, Underland G.
    Behav Brain Res; 1989 Aug 01; 34(1-2):117-30. PubMed ID: 2527519
    [Abstract] [Full Text] [Related]

  • 6. Behavioral, sleep-waking and EEG power spectral effects following the two specific 5-HT uptake inhibitors zimeldine and alaproclate in cats.
    Sommerfelt L, Ursin R.
    Behav Brain Res; 1991 Nov 26; 45(2):105-15. PubMed ID: 1838688
    [Abstract] [Full Text] [Related]

  • 7. Sleep-wake and eeg effects following adenosine a1 agonism and antagonism: similarities and interactions with sleep-wake and eeg effects following a serotonin reuptake inhibitor in rats.
    Ursin R, Bjorvatn B.
    Sleep Res Online; 1998 Nov 26; 1(3):119-27. PubMed ID: 11382868
    [Abstract] [Full Text] [Related]

  • 8. Stereoselective antagonism by the pindolol enantiomers of 8-OH-DPAT-induced changes of sleep and wakefulness.
    Monti JM, Jantos H.
    Neuropharmacology; 1994 May 26; 33(5):705-8. PubMed ID: 7936106
    [Abstract] [Full Text] [Related]

  • 9. The selective 5-HT(1A) receptor antagonist p-MPPI antagonizes sleep--waking and behavioural effects of 8-OH-DPAT in rats.
    Sørensen E, Grønli J, Bjorvatn B, Ursin R.
    Behav Brain Res; 2001 Jun 26; 121(1-2):181-7. PubMed ID: 11275295
    [Abstract] [Full Text] [Related]

  • 10. 5-hydroxytryptamine (5-HT)1A receptors and the tail-flick response. I. 8-hydroxy-2-(di-n-propylamino) tetralin HBr-induced spontaneous tail-flicks in the rat as an in vivo model of 5-HT1A receptor-mediated activity.
    Millan MJ, Bervoets K, Colpaert FC.
    J Pharmacol Exp Ther; 1991 Mar 26; 256(3):973-82. PubMed ID: 1826033
    [Abstract] [Full Text] [Related]

  • 11. Effects of the selective 5-hydroxytryptamine uptake inhibitors paroxetine and zimeldine on EEG sleep and waking stages in the rat.
    Kleinlogel H, Burki HR.
    Neuropsychobiology; 1987 Mar 26; 17(4):206-12. PubMed ID: 2964564
    [Abstract] [Full Text] [Related]

  • 12. Mediation of the discriminative stimulus properties of 8-hydroxy-2-(di-n-propylamino) tetralin (8-OH-DPAT) by the putative 5-HT1A receptor.
    Tricklebank MD, Neill J, Kidd EJ, Fozard JR.
    Eur J Pharmacol; 1987 Jan 06; 133(1):47-56. PubMed ID: 2881789
    [Abstract] [Full Text] [Related]

  • 13. The effects of zimeldine and alaproclate combined with a small dose of 5-HTP on waking and sleep stages in cats.
    Sommerfelt L, Ursin R.
    Behav Brain Res; 1987 Apr 06; 24(1):1-10. PubMed ID: 2953350
    [Abstract] [Full Text] [Related]

  • 14. Lesion of descending 5-HT pathways increases zimeldine-induced waking in rats.
    Bjørkum AA, Neckelmann D, Bjorvatn B, Ursin R.
    Physiol Behav; 1995 May 06; 57(5):959-66. PubMed ID: 7610150
    [Abstract] [Full Text] [Related]

  • 15. The 5-HT2 antagonist ritanserin decreases sleep in cats.
    Sommerfelt L, Ursin R.
    Sleep; 1993 Jan 06; 16(1):15-22. PubMed ID: 8456229
    [Abstract] [Full Text] [Related]

  • 16. Hypnotic action of flunitrazepam in the rat: does 5-HT mechanism play a role?
    de St Hilaire-Kafi S, Gaillard JM.
    Neuropharmacology; 1988 Dec 06; 27(12):1227-30. PubMed ID: 2977426
    [Abstract] [Full Text] [Related]

  • 17. Sleep/waking effects of a selective 5-HT1A receptor agonist given systemically as well as perfused in the dorsal raphe nucleus in rats.
    Bjorvatn B, Fagerland S, Eid T, Ursin R.
    Brain Res; 1997 Oct 03; 770(1-2):81-8. PubMed ID: 9372206
    [Abstract] [Full Text] [Related]

  • 18. Sleep effects following intrathecal administration of the 5-HT1A agonist 8-OH-DPAT and the NMDA antagonist AP-5 in rats.
    Bjørkum AA, Bjorvatn B, Neckelmann D, Ursin R.
    Brain Res; 1995 Sep 18; 692(1-2):251-8. PubMed ID: 8548311
    [Abstract] [Full Text] [Related]

  • 19. A behavioural and biochemical study in mice and rats of putative selective agonists and antagonists for 5-HT1 and 5-HT2 receptors.
    Goodwin GM, Green AR.
    Br J Pharmacol; 1985 Mar 18; 84(3):743-53. PubMed ID: 2580582
    [Abstract] [Full Text] [Related]

  • 20. Diurnal differences in L-tryptophan sleep and temperature effects in the rat.
    Olsen OE, Neckelmann D, Ursin R.
    Behav Brain Res; 1994 Dec 15; 65(2):195-203. PubMed ID: 7718152
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.